Polvere di propionato di Clobetasol di alta qualità CAS 25122-46-7

area di spedizione
in tutto il mondo/tutti i paesi
n. cas
25122-46-7
saggio
99%
metodo di consegna
fedex/dhl/linea speciale
nome del prodotto
propionato di clobetasol
servizio
servizio buono
conservazione
conservare in luogo fresco e asciutto
metodo di prova
hplc
consegna
express 5-7 giorni arrivo
durata a magazzino
2 anni
aspetto
polvere bianca
Pacchetto di Trasporto
Foil Bag
Specifiche
99%
Marchio
Xi′an Frazer Biotech Co., Ltd.
Origine
China
Capacità di Produzione
200kg Per Month
Prezzo di riferimento
$ 17.10 - 90.00

Descrizione del Prodotto

High Quality Clobetasol Propionate Powder CAS 25122-46-7
High Quality Clobetasol Propionate Powder CAS 25122-46-7
High Quality Clobetasol Propionate Powder CAS 25122-46-7

Specification of Analysis

Product Name  Clobetasol Propionate
 Appearance  white powder
 CAS  25122-46-7
 Other Name  Clobetasolprop
 Grade  Medicine & Feed & Food
 Assay  99%min
 Shelf life  2 Years
 Color  White 

Clobetasol propionate is a corticosteroid used to treat various skin disorders including eczema and psoriasis. It is also highly effective for contact dermatitis caused by exposure to poison ivy/oak. Clobetasol belongs to US Class I (Europe: class IV) of the corticosteroids, making it one of the most potent available. It comes in shampoo, mousse, ointment and emollient cream presentations. It has very high potency and typically should not be used with occlusive dressings, or for extended continuous use (beyond two weeks). It is also used to treat several auto-immune diseases including alopecia areata, vitiligo and lichen planus (auto immune skin nodules).

Function

Clobetasol propionate is used for the treatment of various skin disorders including eczema, psoriasis, and lichen sclerosus. It is also used to treat several auto-immune diseases including alopecia areata, vitiligo, lichen planus (auto immune skin nodules), and mycosis fungoides (T-cell skin lymphoma).

 

 

 
 
 
 
 
 

 

Mediatore Farmaceutico

DREAMKITCHEN.PT, 2023